Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT06396871 Sponsor: Technische Universität Dresden Condition: Non-Alcoholic Fatty Liver Disease
Back to Non Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease Trial, Recruiting

NCT06396871
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be over 18 years old.
  • You may join as a "case" participant if you fall into one of these groups:
    • Liver scarring risk group: You have both a FIB-4 score of 1.3 or higher AND a liver stiffness scan result of 8 kPa or higher (confirm with trial site).
    • Fatty liver group: An ultrasound has shown fat in your liver AND a related scan measurement is above a certain level (confirm with trial site).
    • Prediabetes group: Your blood sugar levels are slightly above normal, based on one or more standard blood sugar tests.
    • Diabetes group: You have been diagnosed with type 2 diabetes, confirmed by one or more standard blood sugar tests.
  • If you do not meet the "case" criteria above, you may still be able to join as a "control" (comparison) participant if your liver scan, ultrasound, and blood sugar results are all within normal ranges.

Who may not be able to join:

  • People who have type 1 diabetes.
  • People with a BMI below 18.5 (considered underweight).
  • People who have had a blood transfusion or significant bleeding in the last six months.
  • People with severe anaemia (very low haemoglobin levels).
  • People with chronic alcohol or drug misuse problems.
  • People who have any liver disease other than non-alcoholic fatty liver disease (for example, viral hepatitis, autoimmune hepatitis, or certain inherited liver conditions).
  • People with an active systemic infection or high inflammation levels in their blood (confirm with trial site).
  • People who have taken medications that affect blood sugar levels (such as steroids or diabetes medications, unless joining as a diabetes participant) in the last six months.
  • People who have taken blood-thinning or anti-clotting medications in the last six months.
  • People who have taken medications that affect the immune system in the last six months.
  • People who are pregnant or breastfeeding.
  • People with severe mental health conditions.
  • People who are unable to follow the study procedures for any reason.
  • People with any other medical condition that the trial doctor considers unsuitable for participation.

Additional reasons someone may not be able to have the MRI scan part of the trial:

  • Having a pacemaker or artificial heart valve.
  • Having metal implants, prostheses, or any surgically implanted magnetic metal parts.
  • Having certain types of coils or spirals implanted in the body (confirm with trial site).
  • Having fixed metal dental braces.
  • Having acupuncture needles in place.
  • Using an insulin pump.
  • Having tattoos or permanent eyeliner, if the MRI machine used is above 3 Tesla strength.
  • Having claustrophobia or a condition that prevents you from completing the MRI scan.
  • Having a body size that does not allow you to fit in the MRI scanner.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +4935145813651

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Technische Universität Dresden
Registry
ClinicalTrials.gov
Start date
16 October 2023
Est. completion
31 December 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Qualitative differences in platelets; Quantitative differences in platelets

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov